Thus, in a cancer-dependent context, lncRNAs may be overexpressed to either inhibit or decrease the level of PTEN targeting microRNAs, thereby increasing PTEN expression and activity as a tumour suppressor. The gene discussed is PTEN; the disease is cancer.